Serotonin syndrome: Difference between revisions
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
#Altered Mental Status: Agitated delirium | #Altered Mental Status: Agitated delirium | ||
#Autonomic Instability: Hyperthermia, Tachycardia, diaphoresis | #Autonomic Instability: Hyperthermia, Tachycardia, diaphoresis | ||
#Neuromuscular Abnormalities: Myoclonus, ocular clonus, rigidity, | #Neuromuscular Abnormalities: Myoclonus, ocular clonus, rigidity, hyperreflexia, tremor | ||
##More pronounced in the lower extremities | ##More pronounced in the lower extremities | ||
Revision as of 15:48, 23 February 2012
Background
- Can be produced by any serotonergic medication
- Vast majority of cases occur with therapeutic dosages
- Most common cause of death is severe hyperthermia
Causative Agents
- SSRIs
- MAOIs
- TCAs
- Drugs of Abuse: Cocaine, Ecstasy, Marijuana
- Analgesics: Demerol, fentanyl
- Antiemetics
- Triptans
- Bromocriptine
- OTC: Cough meds, herbal products, St John’s Wort
Clinical Features
- Altered Mental Status: Agitated delirium
- Autonomic Instability: Hyperthermia, Tachycardia, diaphoresis
- Neuromuscular Abnormalities: Myoclonus, ocular clonus, rigidity, hyperreflexia, tremor
- More pronounced in the lower extremities
Diagnosis
- Hunter Toxicity Criteria Decision Rules
- 84% Sn, 97% Sp
- Serotonergic agent plus 1 of the following:
- Spontaneous clonus
- Inducible clonus AND (agitation or diaphoresis)
- Ocular Clonus AND (agitation or diaphoresis)
- Tremor AND hyperreflexia
- Hypertonia AND temp >38 AND (ocular clonus or inducible clonus)
DDX
- Neuroleptic Malignant Syndrome (NMS)
- Anticholinergic toxicity
- Malignant Hyperthermia
- Sympathomimetic toxicity
- Meningitis/encephalitis
Treatment
- Discontinue all serotonergic drugs
- Benzos
- Goal is to eliminate agitation, neuromuscular abnormalities, elevations in HR/BP
- Cyproheptadine
- Give if benzos and supportive care fail to improve agitation and abnormal vitals
- Serotonin antagonist
- Give 12mg PO/NG; repeat with 2mg q2hr until clinical response is seen (max 32mg/d)
- Give 4mg q6hr x48hr if pt is responsive to initial dose
- Treat hyperthermia
- Hyperthermia due to increase in muscular activity, not change in set point
- Intubate and paralyze
- Standard cooling measures
Source
- Tintinalli
- UpToDate